Rubicon Genomics

About:

Rubicon Genomics was founded in 2000 by two University of Michigan faculty members, Dr. John Langmore and Dr. Vladimir Makarov, who wanted

Website: http://www.rubicongenomics.com

Twitter/X: rubicongenomics

Top Investors: BroadOak Capital Partners, Research Corporation Technologies, Duchossois Technology Partners, Aria Ventures, Arch Development Partners

Description:

Rubicon Genomics was founded in 2000 by two University of Michigan faculty members, Dr. John Langmore and Dr. Vladimir Makarov, who wanted to advance the translation of human genetics “laboratory knowledge” into practical medicine applications. The founders also decided to maintain the company’s roots in Michigan with a commitment to supporting the Michigan economy. Today, Rubicon Genomics is a privately held company located in Ann Arbor, Michigan and employs 20 administrative and technical staff. Our innovative products combined with our strategic partnerships have established the company as a leader in pre-analytical amplification technologies that "break the sample barriers" for our customers. Rubicon sells its products into the research and commercial markets directly and through distributors

Total Funding Amount:

$5.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Ann Arbor, Michigan, United States

Founded Date:

2000-01-01

Contact Email:

sales(AT)rubicongenomics.com

Founders:

John Langmore, Vladimir Makarov

Number of Employees:

11-50

Last Funding Date:

2015-07-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai